002004.SZ
002004.SZ
CNE000001JJ6
HUAPONT LIFESCIENCES
Loading chart...

Company Profile

Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. It is involved in the production and sale of pharmaceutical preparations and raw materials. The company also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management products. In addition, it provides pesticide technical, intermediate and preparation products, and GLP registration technical services. Further, the company engages in the research and development, production, and sales of fine chemical products and polymer materials, as well as provides tourism services and agent for the promotion of preparation products. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co.,Ltd. in September 2015. Huapont Life Sciences Co.,Ltd. was founded in 1992 and is headquartered in Chongqing, China.

Related stocks

603599.SS
603599.SS • China
ANHUI GUANGXIN AGR
10.46 CNY
1.42B USD 1Y -11.5%
002588.SZ
002588.SZ • China
STANLEY
7.62 CNY
1.31B USD 1Y -17.6%
002170.SZ
002170.SZ • China
BATIAN
10.83 CNY
1.57B USD 1Y -3.3%
002215.SZ
002215.SZ • China
NOPOSION
9.41 CNY
1.41B USD 1Y -25%
600389.SS
600389.SS • China
NANTONG JIANGSHAN AGROCHEMICAL
18.11 CNY
1.17B USD 1Y -28.3%
002258.SZ
002258.SZ • China
LIER CHEMICAL
13.99 CNY
1.68B USD 1Y +9%
301035.SZ
301035.SZ • China
RAINBOW CHEMICAL
48.41 CNY
2.64B USD 1Y -21.1%
600230.SS
600230.SS • China
CANGZHOU DAHUA CO LTD
13.74 CNY
851.09M USD 1Y +10.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.9% p.a.
Max Drawdown (5Y)
-51.0%
Sharpe Ratio (5Y)
-0.35
Beta Factor
0.32
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -62.6% in the extended horizon.
ende